Suchergebnisse - "Zameer, Saima"

PubPharm (46)

1

Retraction Note : Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular Aβ1-42 rat model of Alzheimer's disease through modulations of hippocampal cAMP/cGMP/BDNF signaling pathway

enthalten in: Pharmacological reports : PR | 2023

von Hasan, N. | Zameer, S. | Najmi, A. | +3

RetractionOf: Pharmacol Rep. 2021 Oct;73(5):1287-1302. - PMID 33860460

2

Retraction Note: Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular Aβ1–42 rat model of Alzheimer’s disease through modulations of hippocampal cAMP/cGMP/BDNF signaling pathway

enthalten in: Pharmacological reports | 2023

von Hasan, N. | Zameer, S. | Najmi, A. | +3

3

Corrigendum to "Ameliorative effect of alendronate against intracerebroventricular streptozotocin induced alteration in neurobehavioral, neuroinflammation and biochemical parameters with emphasis on Aβ and BACE-1" [Neurotoxicology 70 (2019) pp. 122-134

enthalten in: Neurotoxicology | 2023

von Zameer, S. | Kaundal, M. | Vohora, D. | +3

ErratumFor: Neurotoxicology. 2019 Jan;70:122-134. - PMID 30481507

4

Responses for the concerns raised for "alendronate reduces the cognitive and neurological disturbances induced by combined doses of d-galactose and aluminum chloride in mice" (https://doi.org/10.1002/jat.4160) in Journal of Applied Toxicology

enthalten in: Journal of applied toxicology : JAT | 2023

von Zameer, S. | Hussain, S. | Vohora, D. | +3

ErratumFor: J Appl Toxicol. 2021 Nov;41(11):1779-1793. - PMID 33694194

5

Insights into Pharmacological Potential of Apigenin through Various Pathways on a Nanoplatform in Multitude of Diseases

enthalten in: Current pharmaceutical design | 2023

von Waheed, A. | Zameer, S. | Ashrafi, K. | +5

6

Engineering of QbD driven and ultrasonically shaped lyotropic liquid crystalline nanoparticles for Apigenin in the management of skin cancer

enthalten in: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V | 2022

von Waheed, A. | Zameer, S. | Sultana, N. | +4

7

Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer's Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway

enthalten in: Neurotoxicity research | 2022

von Hasan, N. | Zameer, S. | Najmi, A. | +2

8

Effect of the MAGL/FAAH Dual Inhibitor JZL-195 on Streptozotocin-Induced Alzheimer's Disease-like Sporadic Dementia in Mice with an Emphasis on Aβ, HSP-70, Neuroinflammation, and Oxidative Stress

enthalten in: ACS chemical neuroscience | 2022

von Bajaj, S. | Zameer, S. | Jain, S. | +2

9

Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer’s Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway

enthalten in: Neurotoxicity research | 2022

von Hasan, N. | Zameer, S. | Najmi, A. | +2

10

Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer’s Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway

enthalten in: Neurotoxicity research | 2022

von Hasan, N. | Zameer, S. | Najmi, A. | +2

1
2
3
4
5
Nächster »
[5]